4DMedical Statistics

Total Valuation

4DMedical has a market cap or net worth of AUD 2.52 billion. The enterprise value is 2.48 billion.

Market Cap	2.52B
Enterprise Value	2.48B

Important Dates

The last earnings date was Friday, February 27, 2026.

Earnings Date	Feb 27, 2026
Ex-Dividend Date	n/a

Share Statistics

4DMedical has 572.20 million shares outstanding. The number of shares has increased by 33.65% in one year.

Current Share Class	572.20M
Shares Outstanding	572.20M
Shares Change (YoY)	+33.65%
Shares Change (QoQ)	-62.76%
Owned by Insiders (%)	3.84%
Owned by Institutions (%)	1.12%
Float	470.65M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	434.29
PB Ratio	-88.84
P/TBV Ratio	n/a
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	-14.32
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	-74.66

Financial Position

The company has a current ratio of 6.57

Current Ratio	6.57
Quick Ratio	6.19
Debt / Equity	n/a
Debt / EBITDA	n/a
Debt / FCF	-0.31
Interest Coverage	-0.36

Financial Efficiency

Return on equity (ROE) is -1,099.31% and return on invested capital (ROIC) is -135.72%.

Return on Equity (ROE)	-1,099.31%
Return on Assets (ROA)	-26.14%
Return on Invested Capital (ROIC)	-135.72%
Return on Capital Employed (ROCE)	-38.89%
Weighted Average Cost of Capital (WACC)	23.78%
Revenue Per Employee	46,858
Profits Per Employee	-1.39M
Employee Count	124
Asset Turnover	0.05
Inventory Turnover	0.49

Taxes

Income Tax	-1.03M
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +951.95% in the last 52 weeks. The beta is 2.78, so 4DMedical's price volatility has been higher than the market average.

Beta (5Y)	2.78
52-Week Price Change	+951.95%
50-Day Moving Average	3.88
200-Day Moving Average	1.77
Relative Strength Index (RSI)	54.36
Average Volume (20 Days)	5,597,719

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, 4DMedical had revenue of AUD 5.81 million and -172.93 million in losses. Loss per share was -0.41.

Revenue	5.81M
Gross Profit	5.34M
Operating Income	-50.52M
Pretax Income	-173.95M
Net Income	-172.93M
EBITDA	-48.89M
EBIT	-50.52M
Loss Per Share	-0.41

Full Income Statement

Balance Sheet

The company has 56.76 million in cash and 10.24 million in debt, giving a net cash position of 46.52 million or 0.08 per share.

Cash & Cash Equivalents	56.76M
Total Debt	10.24M
Net Cash	46.52M
Net Cash Per Share	0.08
Equity (Book Value)	-28.40M
Book Value Per Share	-0.06
Working Capital	53.90M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -32.99 million and capital expenditures -186,590, giving a free cash flow of -33.17 million.

Operating Cash Flow	-32.99M
Capital Expenditures	-186,590
Free Cash Flow	-33.17M
FCF Per Share	-0.06

Full Cash Flow Statement

Margins

Gross Margin	91.87%
Operating Margin	-869.40%
Pretax Margin	-2,993.83%
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

4DMedical does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-33.65%
Shareholder Yield	-33.65%
Earnings Yield	-6.85%
FCF Yield	-1.31%

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Altman Z-Score	n/a
Piotroski F-Score	2